Research Review Act of 2004
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Became Public Law No: 108-427.
November 30, 2004
View full timeline
Introduced in House
October 5, 2004
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
October 5, 2004
Mr. Bilirakis moved to suspend the rules and pass the bill, as amended.
October 6, 2004 • 4:23 PM
Considered under suspension of the rules. (consideration: CR H8255-8257)
October 6, 2004 • 4:23 PM
DEBATE - The House proceeded with forty minutes of debate on H.R. 5213.
October 6, 2004 • 4:23 PM
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
October 6, 2004 • 4:34 PM
Considered as unfinished business. (consideration: CR H8650-8651)
October 7, 2004 • 11:42 AM
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 418 - 0 (Roll no. 504).(text: CR 10/6/2004 H8255)
October 7, 2004 • 11:50 AM
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 418 - 0 (Roll no. 504). (text: CR 10/6/2004 H8255)
October 7, 2004 • 11:50 AM
Motion to reconsider laid on the table Agreed to without objection.
October 7, 2004 • 11:50 AM
Received in the Senate, read twice.
October 8, 2004
Passed Senate without amendment by Unanimous Consent. (consideration: CR S11389)
November 16, 2004
Message on Senate action sent to the House.
November 16, 2004
Presented to President.
November 19, 2004
Signed by President.
November 30, 2004
Became Public Law No: 108-427.
November 30, 2004
Voting History
1 vote recorded • Roll call available
Floor Debate
11 membersWhat members said about H.R. 5213 on the floor




+6
Floor Debate
11 membersWhat members said about H.R. 5213 on the floor
Mr. Speaker, I offer a motion to instruct conferees. Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, this motion to instruct House conferees is straightforward. It is a motion to…
Mr. Speaker, I thank the gentleman for yielding me this time, and I am pleased that the gentleman from Kentucky has accepted the Sabo motion, but I want to express a caution. It does the country no…
Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 5213) to expand research information regarding multidisciplinary research projects and epidemiological studies, as amended. Mr.…
Mr. Speaker, I ask unanimous consent to take from the Speaker's table the bill (H.R. 4567) making appropriations for the Department of Homeland Security for the fiscal year ending September 30, 2005,…
Mr. Speaker, I thank the gentleman for yielding me time. Mr. Speaker, I think Members on both sides of the aisle have the same intention, that is, to make America as safe as it needs to be, but I do…
Show 7 more
Mr. Speaker, I yield myself 3 minutes. Mr. Speaker, over the past 20 or so years, overall inpatient, that is hospital and rehabilitation, overall inpatient days for those living with paralysis have…
Mr. Speaker, I rise today in support of this measure, H.R. 5213, the Research Review Act of 2004. This bill represents an important step forward in a long struggle by so many important people in the…
Mr. Speaker, I submit the following correspondence for the Record. House of Representatives, Committee on Ways and Means, Washington, DC, October 6, 2004. Hon. Joe Barton, Chairman, Committee on…
Mr. Speaker, official business in my district prevents me from being present for legislative business scheduled for today, Thursday, October 7, 2004. Had I been present, I would have voted ``aye'' on…
I ask unanimous consent that the Senate now proceed to the immediate consideration of H.R. 5213. I ask unanimous consent that the bill be read a third time and passed, the motion to reconsider be…
Mr. Speaker, on rollcall No. 502, I was in my Congressional District on official business. Had I been present, I would have voted ``yea.''
Mr. Speaker, on rollcall No. 504, I was in my Congressional District on official business. Had I been present, I would have voted ``yea.''
Bill Text
5 versions available
[Congressional Bills 108th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5213 Enrolled Bill (ENR)]
H.R.5213
One Hundred Eighth Congress
of the
United States of America
AT THE SECOND SESSION
Begun and held at the City of Washington on Tuesday,
the twentieth day of January, two thousand and four
An Act
To expand research information regarding multidisciplinary research
projects and epidemiological studies.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Research Review Act of 2004''.
SEC. 2. MULTI-DISCIPLINARY RESEARCH TEAM AND CONSORTIA REPORT.
(a) In General.--The Secretary of Health and Human Services
(referred to in this Act as the ``Secretary''), in coordination with
the Director of the National Institutes of Health, shall prepare a
report outlining the methods by which the Roadmap for Medical Research,
an initiative of such Institutes, has advanced the use of
multidisciplinary research teams and consortia of research institutions
to advance treatments, develop new therapies, and collaborate on
clinical trials, including with respect to spinal cord injury and
paralysis research.
(b) Report.--Not later than February 1, 2005, the Secretary shall
submit the report under subsection (a) to the Committee on Energy and
Commerce of the House of Representatives and to the Committee on
Health, Education, Labor, and Pensions of the Senate.
SEC. 3. EPIDEMIOLOGICAL STUDY REPORT.
(a) In General.--The Secretary, acting through the Director of the
Centers for Disease Control and Prevention, shall prepare a report
outlining the epidemiological studies currently under way at such
Centers, future planned studies, the criteria involved in determining
what epidemiological studies to conduct, defer, or suspend, and the
scope of those studies, including with respect to the inflammatory
bowel disease epidemiological study. The report shall include a
description of the activities the Centers for Disease Control and
Prevention undertakes to establish partnerships with research and
patient advocacy communities to expand epidemiological studies.
(b) Report.--Not later than May 1, 2005, the Secretary shall submit
the report under subsection (a) to the Committee on Energy and Commerce
of the House of Representatives and to the Committee on Health,
Education, Labor, and Pensions of the Senate.
SEC. 4. STUDY BY GOVERNMENT ACCOUNTABILITY OFFICE ON MEDICARE AND
MEDICAID COVERAGE STANDARDS.
(a) In General.--The Comptroller General of the United States shall
conduct a study on the coverage standards that, under the programs
under titles XVIII and XIX of the Social Security Act (commonly known
as Medicare and Medicaid, respectively), apply to patients with
inflammatory bowel disease for the following therapies:
(1) Parenteral nutrition.
(2) Enteral nutrition formula.
(3) Medically necessary food products.
(4) Ostomy supplies.
(5) Therapies approved by the Food and Drug Administration for
Crohn's disease and ulcerative colitis.
(b) Content.--The study under subsection (a) shall take into
account the appropriate outpatient or home health care delivery
settings.
(c) Report.--Not later than six months after the date of the
enactment of this Act, the Comptroller General shall submit to the
Congress a report describing the findings of the study under subsection
(a).
SEC. 5. STUDY BY GOVERNMENT ACCOUNTABILITY OFFICE INVOLVING DISABILITY
INSURANCE.
(a) In General.--The Comptroller General of the United States shall
conduct a study of the problems patients encounter when applying for
disability insurance benefits under title II of the Social Security
Act. The study shall include recommendations for improving the
application process for patients with inflammatory bowel disease.
(b) Report.--Not later than six months after the date of the
enactment of this Act, the Comptroller General shall submit to the
Congress a report describing the findings of the study under subsection
(a).
Speaker of the House of Representatives.
Vice President of the United States and
President of the Senate.